1
|
Nardone D, Ciaramella A, Cerreta M, Pulcrano S, Bellenchi GC, Leone L, Manco G, Febbraio F. Selymatra: A web application for protein-profiling analysis of mass spectra. Biotechnol Appl Biochem 2022; 69:1821-1829. [PMID: 34487563 PMCID: PMC9912196 DOI: 10.1002/bab.2249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Accepted: 08/23/2021] [Indexed: 11/06/2022]
Abstract
Surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry is a variant of the matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry. It is used in many cases especially for the analysis of protein profiling and for preliminary screening of biomarkers in complex samples. Unfortunately, these analyses are time consuming and protein identification is generally strictly limited. SELDI-TOF analysis of mass spectra (SELYMATRA) is a web application (WA) developed to reduce these limitations by (i) automating the identification processes and (ii) introducing the possibility to predict proteins in complex mixtures from cells and tissues. The WA architectural pattern is the model-view-controller, commonly used in software development. The WA compares the mass value between two mass spectra (sample vs. control) to extract differences, and, according to the set parameters, it queries a local database to predict most likely proteins based on their masses and different expression amplification. The WA was validated in a cellular model overexpressing a tagged NURR1 receptor, being able to recognize the tagged protein in the profiling of transformed cells. A help page, including a description of parameters for WA use, is available on the website.
Collapse
Affiliation(s)
- Davide Nardone
- Department of Science and TechnologyUniversity of Naples ParthenopeNaplesItaly
| | - Angelo Ciaramella
- Department of Science and TechnologyUniversity of Naples ParthenopeNaplesItaly
| | - Mariangela Cerreta
- Institute of Biochemistry and Cellular BiologyNational Research CouncilNaples80131Italy
| | - Salvatore Pulcrano
- Institute of Genetic and Biophysics “A. Buzzati Traverso”National Research CouncilNaplesItaly
| | - Gian C. Bellenchi
- Institute of Genetic and Biophysics “A. Buzzati Traverso”National Research CouncilNaplesItaly
| | - Linda Leone
- Department of Chemical SciencesUniversity of Naples “Federico II”Naples80126Italy
| | - Giuseppe Manco
- Institute of Biochemistry and Cellular BiologyNational Research CouncilNaples80131Italy
| | - Ferdinando Febbraio
- Institute of Biochemistry and Cellular BiologyNational Research CouncilNaples80131Italy
| |
Collapse
|
2
|
Abstract
Gonadotropins are glycoprotein sex hormones regulating development and reproduction and bind to specific G protein–coupled receptors expressed in the gonads. Their effects on multiple signaling cascades and intracellular events have recently been characterized using novel technological and scientific tools. The impact of allosteric modulators on gonadotropin signaling, the role of sugars linked to the hormone backbone, the detection of endosomal compartments supporting signaling modules, and the dissection of different effects mediated by these molecules are areas that have advanced significantly in the last decade. The classic view providing the exclusive activation of the cAMP/protein kinase A (PKA) and the steroidogenic pathway by these hormones has been expanded with the addition of novel signaling cascades as determined by high-resolution imaging techniques. These new findings provided new potential therapeutic applications. Despite these improvements, unanswered issues of gonadotropin physiology, such as the intrinsic pro-apoptotic potential to these hormones, the existence of receptors assembled as heteromers, and their expression in extragonadal tissues, remain to be studied. Elucidating these issues is a challenge for future research.
Collapse
Affiliation(s)
- Livio Casarini
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy
- Center for Genomic Research, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy
| | - Manuela Simoni
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy
- Center for Genomic Research, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy
- Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria di Modena, Via P. Giardini 1355, 41126 Modena, Italy
| |
Collapse
|
3
|
Al Matari A, Combès A, Camperi J, Fournier T, Pichon V, Delaunay N. Identification and semi-relative quantification of intact glycoforms by nano-LC–(Orbitrap)MS: application to the α-subunit of human chorionic gonadotropin and follicle-stimulating hormone. Anal Bioanal Chem 2020; 412:5729-5741. [DOI: 10.1007/s00216-020-02794-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2020] [Revised: 06/16/2020] [Accepted: 06/26/2020] [Indexed: 12/29/2022]
|
4
|
Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization. Pharmaceuticals (Basel) 2020; 13:ph13070136. [PMID: 32605133 PMCID: PMC7407829 DOI: 10.3390/ph13070136] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 06/26/2020] [Accepted: 06/26/2020] [Indexed: 12/16/2022] Open
Abstract
Exogenous human follicle-stimulating hormone (hFSH), either derived from extraction and purification from the urine or obtained by recombinant technology in the form of follitropin α, β and δ (rFSH), has been used for decades in the treatment of infertility. The main applications of FSH treatment in the woman have been, and still are, ovulation induction in oligo-anovulatory subjects, and stimulation of the development of a cohort of follicles in patients undergoing controlled ovarian stimulation (COS) for in vitro fertilization (IVF). In the last years, two biosimilars of follitropin alfa, rFSH compounds structurally and functionally similar to the originator, have been approved and marketed for clinical use in Europe. Moreover, some other rFSH biosimilars are currently under investigation. The objective of this article is to review the available evidences comparing the efficacy, safety, and cost-effectiveness of rFSH follitropin alpha originator with its biosimilars, discussing the clinical trials that allowed biosimilars to get registration and marketing authorization.
Collapse
|
5
|
Development of a robust reporter gene-based assay for the bioactivity determination of recombinant human follicle stimulating hormone (rhFSH) pharmaceutical products. J Pharm Biomed Anal 2019; 177:112855. [PMID: 31561061 DOI: 10.1016/j.jpba.2019.112855] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2018] [Revised: 08/23/2019] [Accepted: 09/02/2019] [Indexed: 01/18/2023]
Abstract
FSH plays a key role in the function of the reproductive system of human beings and is widely used both diagnostically and therapeutically in reproductive medicine. With the growing incidence of infertility, the demand for FSH pharmaceutical products is increasing. For this reason, the quality control process for FSH products is becoming more stringent. An accurate determination of bioactivity is crucial for the safety and efficacy of recombinant human follicle stimulating hormone (rhFSH). Up to now, in-vivo bioassay based on FSH-induced increases in rat ovarian weight has been the only method widely accepted by different pharmacopoeias. However this method has such drawbacks as the complex procedures, long assay period and high variability. Here, we established a reporter gene assay (RGA) based on the CHO-K1-FSHR-CRE-Luc cell line that stably expresses human follicle stimulating hormone receptor (hFSHR), as well as a luciferase reporter under the control of cyclic adenosine monophosphate (cAMP) response elements (CRES). Our study showed that our new assay not only has good dose-dependent responsiveness to rhFSH, but it also performs excellently in terms of specificity, precision, linearity, and simplicity compared with in-vivo rat bioassays. These results implied that this robust reporter gene assay may be a viable supplement to the animal in-vivo bioassay and may be employed in potency determination of rhFSH pharmaceutical products.
Collapse
|
6
|
Singh SK, Nage N, Jagani H, Maiti M, Ranbhor RS. Glycan mapping of recombinant human follicle stimulating hormone by mass spectrometry. Reprod Biol 2018; 18:380-384. [PMID: 30344088 DOI: 10.1016/j.repbio.2018.10.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2018] [Revised: 10/03/2018] [Accepted: 10/05/2018] [Indexed: 11/25/2022]
Abstract
In humans, regulation of reproductive functions are carried out mainly by glycoprotein hormones namely follicle stimulating hormone (FSH), thyroid stimulating hormone (TSH), luteinizing hormone (LH) and chorionic gonadotropin (CG). Since glycans play an important role in binding of gonadotropins with their respective receptors, it is important to identify associated glycans and their pharmacological properties not only for the disease manipulation but also for making more efficacious and safer recombinant versions. With the advancement of mass spectrometry, it is possible to identify minute quantity of associated glycans. Here, we studied the N-glycans of the FSH based on mass spectrometry and report one more complex glycan species in addition to twenty four previously reported glycans. The new glycan was a tetra antennary species that may have important role in binding of FSH with receptor with higher biological activity as well as lower clearance rate and higher half-life.
Collapse
Affiliation(s)
- Sanjay Kumar Singh
- Sun Pharmaceutical Industries Limited, Tandalja, Vadodara, 390012, India
| | - Nitin Nage
- Sun Pharmaceutical Industries Limited, Tandalja, Vadodara, 390012, India
| | - Hitesh Jagani
- Sun Pharmaceutical Industries Limited, Tandalja, Vadodara, 390012, India
| | - Mukul Maiti
- Sun Pharmaceutical Industries Limited, Tandalja, Vadodara, 390012, India
| | | |
Collapse
|
7
|
Bousfield GR, May JV, Davis JS, Dias JA, Kumar TR. In Vivo and In Vitro Impact of Carbohydrate Variation on Human Follicle-Stimulating Hormone Function. Front Endocrinol (Lausanne) 2018; 9:216. [PMID: 29867757 PMCID: PMC5960776 DOI: 10.3389/fendo.2018.00216] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/05/2018] [Accepted: 04/17/2018] [Indexed: 12/11/2022] Open
Abstract
Human follicle-stimulating hormone (FSH) exhibits both macro- and microheterogeneity in its carbohydrate moieties. Macroheterogeneity results in three physiologically relevant FSHβ subunit variants, two that possess a single N-linked glycan at either one of the two βL1 loop glycosylation sites or one with both glycans. Microheterogeneity is characterized by 80 to over 100 unique oligosaccharide structures attached to each of the 3 to 4 occupied N-glycosylation sites. With respect to its receptor, partially glycosylated (hypo-glycosylated) FSH variants exhibit higher association rates, greater apparent affinity, and greater occupancy than fully glycosylated FSH. Higher receptor binding-activity is reflected by greater in vitro bioactivity and, in some cases, greater in vivo bioactivity. Partially glycosylated pituitary FSH shows an age-related decline in abundance that may be associated with decreased fertility. In this review, we describe an integrated approach involving genetic models, in vitro signaling studies, FSH biochemistry, relevance of physiological changes in FSH glycoform abundance, and characterize the impact of FSH macroheterogeneity on fertility and reproductive aging. We will also address the controversy with regard to claims of a direct action of FSH in mediating bone loss especially at the peri- and postmenopausal stages.
Collapse
Affiliation(s)
- George R. Bousfield
- Department of Biological Sciences, Wichita State University, Wichita, KS, United States
- *Correspondence: George R. Bousfield,
| | - Jeffrey V. May
- Department of Biological Sciences, Wichita State University, Wichita, KS, United States
| | - John S. Davis
- Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, United States
- Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, United States
- Nebraska-Western Iowa Health Care System, Omaha, NE, United States
| | - James A. Dias
- Department of Biomedical Sciences, School of Public Health, University at Albany, Albany, NY, United States
| | - T. Rajendra Kumar
- Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
| |
Collapse
|
8
|
Hassan AA, Maldonado RF, Dos Santos SC, Di Lorenzo F, Silipo A, Coutinho CP, Cooper VS, Molinaro A, Valvano MA, Sá-Correia I. Structure of O-Antigen and Hybrid Biosynthetic Locus in Burkholderia cenocepacia Clonal Variants Recovered from a Cystic Fibrosis Patient. Front Microbiol 2017. [PMID: 28642745 PMCID: PMC5462993 DOI: 10.3389/fmicb.2017.01027] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Burkholderia cenocepacia is an opportunistic pathogen associated with chronic lung infections and increased risk of death in patients with cystic fibrosis (CF). In this work, we investigated the lipopolysaccharide (LPS) of clinical variants of B. cenocepacia that were collected from a CF patient over a period of 3.5 years, from the onset of infection until death by necrotizing pneumonia (cepacia syndrome). We report the chemical structure of the LPS molecule of various sequential isolates and the identification of a novel hybrid O-antigen (OAg) biosynthetic cluster. The OAg repeating unit of the LPS from IST439, the initial isolate, is a [→2)-β-D-Ribf-(1→4)-α-D-GalpNAc-(1→] disaccharide, which was not previously described in B. cenocepacia. The IST439 OAg biosynthetic gene cluster contains 7 of 23 genes that are closely homologous to genes found in B. multivorans, another member of the Burkholderia cepacia complex. None of the subsequent isolates expressed OAg. Genomic sequencing of these isolates enabled the identification of mutations within the OAg cluster, but none of these mutations could be associated with the loss of OAg. This study provides support to the notion that OAg LPS modifications are an important factor in the adaptation of B. cenocepacia to chronic infection and that the heterogeneity of OAgs relates to variation within the OAg gene cluster, indicating that the gene cluster might have been assembled through multiple horizontal transmission events.
Collapse
Affiliation(s)
- A A Hassan
- Department of Bioengineering, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de LisboaLisboa, Portugal
| | - Rita F Maldonado
- Department of Bioengineering, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de LisboaLisboa, Portugal
| | - Sandra C Dos Santos
- Department of Bioengineering, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de LisboaLisboa, Portugal
| | - Flaviana Di Lorenzo
- Department of Chemical Sciences, University of Napoli Federico II Complesso Universitário Monte SantangeloNapoli, Italy
| | - Alba Silipo
- Department of Chemical Sciences, University of Napoli Federico II Complesso Universitário Monte SantangeloNapoli, Italy
| | - Carla P Coutinho
- Department of Bioengineering, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de LisboaLisboa, Portugal
| | - Vaughn S Cooper
- Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, PittsburghPA, United States
| | - Antonio Molinaro
- Department of Chemical Sciences, University of Napoli Federico II Complesso Universitário Monte SantangeloNapoli, Italy
| | - Miguel A Valvano
- The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University BelfastBelfast, United Kingdom
| | - Isabel Sá-Correia
- Department of Bioengineering, Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de LisboaLisboa, Portugal
| |
Collapse
|
9
|
Grünwald-Gruber C, Altmann F. Letter to the Editor regarding “Analysis of recombinant human follicle-stimulating hormone by mass spectrometric approaches”. Anal Bioanal Chem 2017; 409:3899-3900. [DOI: 10.1007/s00216-017-0337-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2017] [Accepted: 03/22/2017] [Indexed: 10/19/2022]
|
10
|
Cimini D, Corte KD, Finamore R, Andreozzi L, Stellavato A, Pirozzi AVA, Ferrara F, Formisano R, De Rosa M, Chino M, Lista L, Lombardi A, Pavone V, Schiraldi C. Production of human pro-relaxin H2 in the yeast Pichia pastoris. BMC Biotechnol 2017; 17:4. [PMID: 28088197 PMCID: PMC5237503 DOI: 10.1186/s12896-016-0319-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2016] [Accepted: 12/07/2016] [Indexed: 12/16/2022] Open
Abstract
Background Initially known as the reproductive hormone, relaxin was shown to possess other therapeutically useful properties that include extracellular matrix remodeling, anti-inflammatory, anti-ischemic and angiogenic effects. All these findings make relaxin a potential drug for diverse medical applications. Its precursor, pro-relaxin, is an 18 kDa protein, that shows activity in in vitro assays. Since extraction of relaxin from animal tissues raises several issues, prokaryotes and eukaryotes were both used as expression systems for recombinant relaxin production. Most productive results were obtained when using Escherichia coli as a host for human relaxin expression. However, in such host, relaxin precipitated in the form of inclusion bodies and, therefore, required several expensive recovery steps as cell lysis, refolding and reduction. Results To overcome the issues related to prokaryotic expression here we report the production and purification of secreted human pro-relaxin H2 by using the methylotrophic yeast Pichia pastoris as expression host. The methanol inducible promoter AOX1 was used to drive expression of the native and histidine tagged forms of pro-relaxin H2 in dual phase fed-batch experiments on the 22 L scale. Both protein forms presented the correct structure, as determined by mass spectrometry and western blotting analyses, and demonstrated to be biologically active in immune enzymatic assays. The presence of the tag allowed to simplify pro-relaxin purification obtaining higher purity. Conclusions This work presents a strategy for microbial production of recombinant human pro-relaxin H2 in Pichia pastoris that allowed the obtainment of biologically active pro-hormone, with a final concentration in the fermentation broth ranging between 10 and 14 mg/L of product, as determined by densitometric analyses. Electronic supplementary material The online version of this article (doi:10.1186/s12896-016-0319-0) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- D Cimini
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy.
| | - K Della Corte
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy
| | - R Finamore
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy
| | - L Andreozzi
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy
| | - A Stellavato
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy
| | - A V A Pirozzi
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy
| | - F Ferrara
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy
| | - R Formisano
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy
| | - M De Rosa
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy
| | - M Chino
- Department of Chemical Sciences, University of Naples Federico II, Via Cintia I, 80126, Naples, Italy
| | - L Lista
- Department of Chemical Sciences, University of Naples Federico II, Via Cintia I, 80126, Naples, Italy
| | - A Lombardi
- Department of Chemical Sciences, University of Naples Federico II, Via Cintia I, 80126, Naples, Italy
| | - V Pavone
- Department of Chemical Sciences, University of Naples Federico II, Via Cintia I, 80126, Naples, Italy
| | - C Schiraldi
- Department of Experimental Medicine, Section of Biotechnology and Molecular Biology, Second University of Naples and University of Campania Luigi Vanvitelli, via de Crecchio 7, 80138, Naples, Italy.
| |
Collapse
|
11
|
Wang H, May J, Butnev V, Shuai B, May JV, Bousfield GR, Kumar TR. Evaluation of in vivo bioactivities of recombinant hypo- (FSH 21/18) and fully- (FSH 24) glycosylated human FSH glycoforms in Fshb null mice. Mol Cell Endocrinol 2016; 437:224-236. [PMID: 27561202 PMCID: PMC5048586 DOI: 10.1016/j.mce.2016.08.031] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2016] [Revised: 08/21/2016] [Accepted: 08/21/2016] [Indexed: 10/21/2022]
Abstract
The hormone - specific FSHβ subunit of the human FSH heterodimer consists of N-linked glycans at Asn7 and Asn24 residues that are co-translationally attached early during subunit biosynthesis. Differences in the number of N-glycans (none, one or two) on the human FSHβ subunit contribute to macroheterogeneity in the FSH heterodimer. The resulting FSH glycoforms are termed hypo-glycosylated (FSH21/18, missing either an Asn24 or Asn7 N-glycan chain on the β - subunit, respectively) or fully glycosylated (FSH24, possessing of both Asn7 and Asn24 N-linked glycans on the β - subunit) FSH. The recombinant versions of human FSH glycoforms (FSH21/18 and FSH24) have been purified and biochemically characterized. In vitro functional studies have indicated that FSH21/18 exhibits faster FSH- receptor binding kinetics and is much more active than FSH24 in every assay tested to date. However, the in vivo bioactivity of the hypo-glycosylated FSH glycoform has never been tested. Here, we evaluated the in vivo bioactivities of FSH glycoforms in Fshb null mice using a pharmacological rescue approach. In Fshb null female mice, both hypo- and fully-glycosylated FSH elicited an ovarian weight gain response by 48 h and induced ovarian genes in a dose- and time-dependent manner. Quantification by real time qPCR assays indicated that hypo-glycosylated FSH21/18 was bioactive in vivo and induced FSH-responsive ovarian genes similar to fully-glycosylated FSH24. Western blot analyses followed by densitometry of key signaling components downstream of the FSH-receptor confirmed that the hypo-glycosylated FSH21/18 elicited a response similar to that by fully-glycosylated FSH24 in ovaries of Fshb null mice. When injected into Fshb null males, hypo-glycosylated FSH21/18 was more active than the fully-glycosylated FSH24 in inducing FSH-responsive genes and Sertoli cell proliferation. Thus, our data establish that recombinant hypo-glycosylated human FSH21/18 glycoform elicits bioactivity in vivo similar to the fully-glycosylated FSH. Our studies may have clinical implications particularly in formulating FSH-based ovarian follicle induction protocols using a combination of different human FSH glycoforms.
Collapse
Affiliation(s)
- Huizhen Wang
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
| | - Jacob May
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
| | - Viktor Butnev
- Department of Biological Sciences, Wichita State University, Wichita, KS 67260, USA
| | - Bin Shuai
- Department of Biological Sciences, Wichita State University, Wichita, KS 67260, USA
| | - Jeffrey V May
- Department of Biological Sciences, Wichita State University, Wichita, KS 67260, USA
| | - George R Bousfield
- Department of Biological Sciences, Wichita State University, Wichita, KS 67260, USA
| | - T Rajendra Kumar
- Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA; Center for Reproductive Sciences, Institute for Reproductive Health and Regenerative Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA; Department of Neurosurgery, University of Kansas Medical Center, Kansas City, KS 66160, USA; Division of Reproductive Sciences, Department of Obstetrics & Gynecology, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO 80045, USA.
| |
Collapse
|
12
|
Yding Andersen C. Inhibin-B secretion and FSH isoform distribution may play an integral part of follicular selection in the natural menstrual cycle. Mol Hum Reprod 2016; 23:16-24. [PMID: 27756855 DOI: 10.1093/molehr/gaw070] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2016] [Revised: 10/08/2016] [Accepted: 10/14/2016] [Indexed: 11/14/2022] Open
Abstract
The aim of the present paper is to expand the concept on how follicular selection takes place in the follicular phase of the natural menstrual cycle. It is suggested that inhibin-B exerts a more intimate role in this process than previously understood. Inhibin-B shows a peak in the circulation around cycle day 7, simultaneous with selection of the dominant follicle, whereas levels of estradiol and inhibin-A only start to increase a few days later suggesting that inhibin-B is mainly responsible for downregulating pituitary FSH release. New data now demonstrate that the circulatory peak of inhibin-B is reflected by peak production of inhibin-B, in contrast to inhibin-A, in the selected follicle with a diameter of 10-12 mm, where concentrations are one thousand times higher than in the circulation. This high inhibin-B concentration also exerts paracrine effects, stimulating theca cell androgen production in concert with LH. New data now suggest that in the corresponding granulosa cells androgens upregulate FSH receptor (FSHR) and LH receptor (LHR) mRNA expression, which in turn stimulate CYP19a mRNA expression providing the follicles which most effectively undertake these processes with the best chance of becoming selected. Inhibin-B production is stimulated by FSH and it appears that the acidic isoforms of FSH induce inhibin-B secretion most efficiently thereby, for the first time, placing the changing FSH isoform profile during the follicular phase in a physiological context. Collectively, it appears that inhibin-B is an integral part of follicular selection in the normal menstrual cycle, exerting both endocrine and paracrine effects and facilitating continued growth of the selected follicle.
Collapse
Affiliation(s)
- C Yding Andersen
- Laboratory of Reproductive Biology, Section 5712, The Juliane Marie Centre for Women, Children and Reproduction, Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 9, Rigshospitalet, DK-2100 Copenhagen, Denmark
| |
Collapse
|
13
|
Wang H, Chen X, Zhang X, Zhang W, Li Y, Yin H, Shao H, Chen G. Comparative Assessment of Glycosylation of a Recombinant Human FSH and a Highly Purified FSH Extracted from Human Urine. J Proteome Res 2016; 15:923-32. [DOI: 10.1021/acs.jproteome.5b00921] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Hong Wang
- Shanghai Institute for Food and Drug Control, Shanghai 201203, China
| | - Xi Chen
- Waters Corporation, Shanghai 201206, China
| | - Xiaoxi Zhang
- Thermo Fisher Scientific, Shanghai 201206, China
| | - Wei Zhang
- Thermo Fisher Scientific, Shanghai 201206, China
| | - Yan Li
- Shanghai Techwell Biopharmaceutical Corporation, Shanghai 201108, China
| | - Hongrui Yin
- Shanghai Institute for Food and Drug Control, Shanghai 201203, China
| | - Hong Shao
- Shanghai Institute for Food and Drug Control, Shanghai 201203, China
| | - Gang Chen
- Shanghai Institute for Food and Drug Control, Shanghai 201203, China
| |
Collapse
|
14
|
Casarini L, Brigante G, Simoni M, Santi D. Clinical Applications of Gonadotropins in the Female: Assisted Reproduction and Beyond. PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE 2016; 143:85-119. [DOI: 10.1016/bs.pmbts.2016.08.002] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
15
|
Santi D, Simoni M. Biosimilar recombinant follicle stimulating hormones in infertility treatment. Expert Opin Biol Ther 2014; 14:1399-409. [DOI: 10.1517/14712598.2014.925872] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
16
|
Sequential (hFSH + recFSH) vs homogenous (hFSH or recFSH alone) stimulation: clinical and biochemical (cumulus cell gene expression) aspects. J Assist Reprod Genet 2014; 31:657-65. [PMID: 24639041 DOI: 10.1007/s10815-014-0208-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2013] [Accepted: 02/28/2014] [Indexed: 01/16/2023] Open
Abstract
FSH is a key hormone in the regulation of follicular development. Together with the EGF network, these molecules mediate oocyte maturation and competence in preparation for the action of LH. FSH isoforms regulate distinct biological pathways and have specific effects on granulosa cell function and maturation of the ovarian follicle. Their dynamic interactions occur during the follicular cycle; short-living forms are predominant in the pre-ovulatory phase, whereas long-acting molecules characterize the luteal-follicular transition. Recombinant FSH (rFSH) molecules have a reduced number of isoforms and are less acidic, with a shorter half-life. We have investigated sequential stimulation, comparing hFSH + rFSH, vs. rFSH alone and hFSH alone for the entire stimulation phase. Sequential stimulation leads to an E2 per MII oocyte ratio that is much lower than is seen during treatment with the two drugs individually. Although there is a positive tendency in favor of the sequential treatment, there was no significant difference in pregnancy rates, even taking frozen embryos into consideration. The cumulus cell transcriptome varies considerably between the treatments, although with no clear significance. When comparing pregnant vs. non-pregnant patients, in general a decrease in mRNA expression can be observed in the pregnant patients, especially in expression of folic acid receptor 1 and ovostatin 2. This indicates that material has been transferred from CC to the oocyte. However, a common observation in the literature is that variations in the transcriptome of the cumulus cells are highly dependent upon the patient genotype; the potential for applying this strategy as a basis for selecting embryos is, at the very least, questionable.
Collapse
|